EIN 82-4322538

Aim Hi Translational Research

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2019
Most recent tax filings
2022-12-01
NTEE code, primary
Description
Aim Hi Translational Research is an independent 501(C)(3) non-profit organization that was established with an initial grant from the National Foundation for Cancer Research. Its mission is to accelerate the translation of cancer drug discoveries by leveraging immediately deployable venture philanthropy funding. It provides seed funding and sustainable impact investment for oncology start-ups to bridge the "Valley of Death" funding gap and bring innovative new therapies, diagnostics, and cancer prevention.
Also known as...
Aim-Hi Accelerator Fund
Total revenues
$3,905,995
2022
Total expenses
$175,685
2022
Total assets
$13,356,814
2022
Num. employees
0
2022

Program areas at Aim Hi Translational Research

Leveraging immediately deployable venture philanthropy funding to provide seed funding and sustainable impact investment for oncology start-ups to bridge the "Valley of Death" funding gap and bring innovative new therapies, diagnostics and cancer prevention to patients.

Who funds Aim Hi Translational Research

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
National Foundation for Cancer Research (NFCR)Collaboration$1,000,000
IncubateFund Start-Up Oncology Companies, Supporting Innovative Laboratory Breakthroughs That Have the Potential To Save the Lives of Cancer Patients.$15,000
The Stephen and Renee Bisciotti FoundationGlobal Summit 2022$10,000

Personnel at Aim Hi Translational Research

NameTitleCompensation
Sujuan BaPresident and Chief Executive Officer$0
Kwok LeungChief Financial Officer$0
Aleksandra FilipovicHead of Oncology, Puretech Health
Beverly Lu, Ph.D.Investment Manager, Health, Emerson

Financials for Aim Hi Translational Research

RevenuesFYE 12/2022
Total grants, contributions, etc.$3,905,995
Program services$0
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$3,905,995

Form 990s for Aim Hi Translational Research

Fiscal year endingDate received by IRSFormPDF link
2022-122023-07-12990View PDF
2021-122022-08-04990View PDF
2020-122021-08-16990View PDF
Data update history
December 24, 2023
Received grants
Identified 2 new grant, including a grant for $1,000,000 from National Foundation for Cancer Research (NFCR)
August 25, 2023
Posted financials
Added Form 990 for fiscal year 2022
August 17, 2023
Posted financials
Added Form 990 for fiscal year 2021
May 12, 2023
Received grants
Identified 1 new grant, including a grant for $1,050,000 from National Foundation for Cancer Research (NFCR)
August 1, 2022
Posted financials
Added Form 990 for fiscal year 2020
Nonprofit Types
Medical research organizationsResearch centersCharities
Issues
Science and technologyHealthDiseases and disorders
Characteristics
Conducts researchTax deductible donationsNo full-time employees
General information
Address
5515 Security LN Suite 1105
Rockville, MD 20852
Metro area
Washington-Arlington-Alexandria, DC-VA-MD-WV
County
Montgomery County, MD
Website URL
aim-hiaccelerator.org/ 
Phone
(301) 654-1250
IRS details
EIN
82-4322538
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2019
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
Free account sign-up

Want updates when Aim Hi Translational Research has new information, or want to find more organizations like Aim Hi Translational Research?

Create free Cause IQ account